Unizentrische, retrospektive Analyse der praktischen Durchführung der extrakorporalen Photopherese

[1]  D. Hannani.  Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma , 2015, Front. Immunol..

[2]  A. Enk,et al.  Guidelines on the use of extracorporeal photopheresis , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  C. Eby,et al.  Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis , 2013, Transfusion.

[4]  M. Klinger,et al.  Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. , 2011, Transplantation proceedings.

[5]  J. Scarisbrick.  Extracorporeal photopheresis: what is it and when should it be used? , 2009, Clinical and experimental dermatology.

[6]  E. Bisaccia,et al.  Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T‐cell lymphoma , 2009, The British journal of dermatology.

[7]  T. Luger,et al.  Extracorporeal photopheresis with permanent subcutaneous right atrial catheters , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[8]  Nicola Pimpinelli,et al.  Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). , 2007, Blood.

[9]  S. Ibbotson,et al.  Evidence‐based practice of photopheresis 1987–2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group , 2006, The British journal of dermatology.

[10]  F. Schooneman.  Extracorporeal photopheresis technical aspects. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[11]  R. Knobler,et al.  Heparin-induced thrombocytopenia: a complication in extracorporeal photochemotherapy (photopheresis). , 2002, Journal of American Academy of Dermatology.

[12]  L. Salvaneschi,et al.  Adverse effects associated with extracorporeal photochemotherapy , 2000, Transfusion.

[13]  T. Price,et al.  Frequency of immediate adverse effects associated with therapeutic apheresis , 1999, Transfusion.

[14]  R. Voll,et al.  Immunosuppressive effects of apoptotic cells , 1997, Nature.

[15]  Y. Shyr,et al.  Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. , 1996, Journal of the American Academy of Dermatology.

[16]  B. Balda,et al.  Treatment of cutaneous T‐cell lymphoma with extracorporeal photochemotherapy , 1996 .

[17]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[18]  A. Maeda.  Extracorporeal photochemotherapy. , 2009, Journal of dermatological science.